Paper54397
Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.
Zinner SH and 1 other. J Infect Dis, 1976. Cited by 91 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. Papers, record 54397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/54397
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Immunoglobulin G | Major topic |
| Immunoglobulin M | Major topic |
| Sepsis | Major topic |
| Antigens, Bacterial | |
| Enterobacteriaceae | |
| Epitopes | |
| Escherichia coli Infections | |
| Humans | |
| Klebsiella Infections | |
| Proteus Infections | |
| Pseudomonas Infections | |
| Serratia | |
| Shock |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29,464,544 | Top Down Tandem Mass Spectrometric Analysis of a Chemically Modified Rough-Type Lipopolysaccharide Vaccine Candidate. | J Am Soc Mass Spectrom | 2018 | https://conductscience.org/library/papers/29464544 | PubMed |
| 24,351,718 | Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect. | Toxins (Basel) | 2013 | https://conductscience.org/library/papers/24351718 | PubMed |
| 7,621,402 | Endotoxemia: methods of detection and clinical correlates. | Clin Microbiol Rev | 1995 | https://conductscience.org/library/papers/7621402 | PubMed |
| 7,591,089 | Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide. | Infect Immun | 1995 | https://conductscience.org/library/papers/7591089 | PubMed |
| 7,365,108 | Circulating immune complexes in patients with gram negative septic shock. | Intensive Care Med | 1980 | https://conductscience.org/library/papers/7365108 | PubMed |
| 7,012,215 | Immunological aspects to severe bacterial sepsis. | Intensive Care Med | 1981 | https://conductscience.org/library/papers/7012215 | PubMed |
| 7,007,413 | Improved serodiagnosis of Salmonella enteric fevers by an enzyme-linked immunosorbent assay. | J Clin Microbiol | 1981 | https://conductscience.org/library/papers/7007413 | PubMed |
| 6,816,583 | Serum-induced lysis of Pseudomonas aeruginosa. | Eur J Clin Microbiol | 1982 | https://conductscience.org/library/papers/6816583 | PubMed |
| 6,465,987 | In vivo and in vitro humoral immunity in surgical patients. | Ann Surg | 1984 | https://conductscience.org/library/papers/6465987 | PubMed |
| 6,343,827 | Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. | Microbiol Rev | 1983 | https://conductscience.org/library/papers/6343827 | PubMed |
| 3,657,701 | A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria. | Med Microbiol Immunol | 1987 | https://conductscience.org/library/papers/3657701 | PubMed |
| 3,410,536 | Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. | Infect Immun | 1988 | https://conductscience.org/library/papers/3410536 | PubMed |
| 3,296,482 | Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis. | World J Surg | 1987 | https://conductscience.org/library/papers/3296482 | PubMed |
| 429,553 | Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. | J Clin Invest | 1979 | https://conductscience.org/library/papers/429553 | PubMed |
| 407,161 | Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant. | Infect Immun | 1977 | https://conductscience.org/library/papers/407161 | PubMed |
| 106,013 | Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions. | Infect Immun | 1979 | https://conductscience.org/library/papers/106013 | PubMed |
| 70,410 | Protective capacity of antibodies against Escherichia coli and K antigens. | Infect Immun | 1977 | https://conductscience.org/library/papers/70410 | PubMed |
| 69,613 | Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants. | Infect Immun | 1977 | https://conductscience.org/library/papers/69613 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/54397
GET https://conductscience.org/api/papers/v1/54397/authors